You are here: Industry Insights > approval

News List

A Review of MS drugs in China PharmaSources/Caicai
July 24, 2019
There are only two MS drugs approved for marketing in China, separately being the interferon beta-1a and teriflunomide...
Overview of the Approval Trends of Pharmaceutical Products in the First Half of 2019 PharmaSources/Suyi
July 11, 2019
Clinically Imperative Overseas New Drugs Approved Accounting for a Larger Number
FDA Grants Accelerated Approval to Selinexor americanpharmaceuticalreview
July 08, 2019
The Food and Drug Administration (FDA) has granted accelerated approval to selinexor (XPOVIO, Karyopharm Therapeutics) in combination with dexamethasone for adult patients with ...
FDA Expands Approval of Cystic Fibrosis Treatment americanpharmaceuticalreview
June 26, 2019
The U.S. Food and Drug Administration (FDA) expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.
WAT Medical receives approval for migraine treatment product biospectrumasia
June 03, 2019
Homemed is WAT Medical's partner in Australia
Genentech Announces FDA Approval for Venclexta Plus Gazyva for People with CLL americanpharmaceuticalreview
May 23, 2019
Genentech announced the U.S. Food and Drug Administration (FDA) has approved Venclexta® (venetoclax) in combination with Gazyva® (obinutuzumab) for the treatment of people with ...
Keytruda/Inlyta combo scores FDA approval in advanced kidney cancer pharmafiles
April 24, 2019
MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) has secured another approval from the FDA, this time as a first-line treatment in combination with Pfizer’s Inlyta (axitinib) in advanced renal cell carcinoma.
Alvogen, Business Partners Obtain First European Approvals for Generic Ulipristal 5mg americanpharmaceuticalreview
April 11, 2019
Alvogen, Business Partners Obtain First European Approvals for Generic Ulipristal 5mg.
Teva’s migraine drug secures European marketing approval pharmaceutical-technology
April 03, 2019
Israel’s Teva Pharmaceutical has received marketing authorisation from the European Commission (EC) for Ajovy (fremanezumab), an injection intended to provide relief from migraines.
Circassia’s COPD drug gets FDA approval pharmatimes
April 02, 2019
Circassia has announced the US Food and Drug Administration (FDA) approval of its chronic obstructive pulmonary disease (COPD) maintenance treatment, Duaklir.

Previous page 1 2 3 4 5 6 7 Next page